HT4 Patient-Relevance of Endpoints Other Than Overall Survival (Non-OS Endpoints) in Oncology Health Technology Assessments by the Federal Joint Committee (G-BA) in Germany
Jun 1, 2021, 00:00
10.1016/j.jval.2021.04.048
https://www.valueinhealthjournal.com/article/S1098-3015(21)00265-5/fulltext
Title :
HT4 Patient-Relevance of Endpoints Other Than Overall Survival (Non-OS Endpoints) in Oncology Health Technology Assessments by the Federal Joint Committee (G-BA) in Germany
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)00265-5&doi=10.1016/j.jval.2021.04.048
First page :
Section Title :
Open access? :
No
Section Order :
11023